Homozygous HTT KO cell lines were created using CRISPR-mediated genome editing of a pancreatic adenocarcinoma cell line PATU8988T, which stably expresses a tagged lysosomal protein, TMEM192-HA (SI Appendix, Fig. S1). The gene discussed is TMEM192; the disease is pancreatic adenocarcinoma.